Centessa Pharmaceuticals plc
CNTA
$39.59
-$0.02-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 294.58M | 246.21M | 250.72M | 284.51M | 482.18M |
| Total Receivables | 60.34M | 52.21M | 44.10M | 52.70M | 45.58M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 773.00K | 1.26M | 233.00K | 375.00K | 840.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.18M | 7.99M | 5.31M | 10.13M | 7.81M |
| Total Current Assets | 367.88M | 307.68M | 300.36M | 347.72M | 536.41M |
|
|
|||||
| Total Current Assets | 367.88M | 307.68M | 300.36M | 347.72M | 536.41M |
| Net Property, Plant & Equipment | 10.85M | 11.19M | 11.27M | 11.46M | 11.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.22M | 26.61M | 27.09M | 28.27M | 28.63M |
| Total Assets | 687.50M | 448.30M | 492.13M | 527.85M | 576.80M |
|
|
|||||
| Total Accounts Payable | 7.58M | 8.68M | 5.69M | 5.13M | 7.14M |
| Total Accrued Expenses | 34.42M | 19.39M | 22.94M | 16.85M | 49.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 713.00K | 684.00K | 656.00K | 629.00K | 602.00K |
| Total Finance Division Other Current Liabilities | 217.00K | 365.00K | 409.00K | 1.59M | 943.00K |
| Total Other Current Liabilities | 217.00K | 365.00K | 409.00K | 1.59M | 943.00K |
| Total Current Liabilities | 42.94M | 29.12M | 29.69M | 24.20M | 58.00M |
|
|
|||||
| Total Current Liabilities | 42.94M | 29.12M | 29.69M | 24.20M | 58.00M |
| Long-Term Debt | 110.10M | 109.82M | 109.55M | 109.25M | 108.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.57M | 7.76M | 7.94M | 8.12M | 8.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Liabilities | 160.63M | 146.73M | 147.21M | 141.60M | 175.25M |
|
|
|||||
| Common Stock & APIC | 1.71B | 1.42B | 1.41B | 1.40B | 1.39B |
| Retained Earnings | -1.19B | -1.12B | -1.07B | -1.01B | -988.70M |
| Treasury Stock & Other | 2.71M | 2.60M | 1.59M | 2.08M | 4.21M |
| Total Common Equity | 526.86M | 301.57M | 344.92M | 386.25M | 401.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 526.86M | 301.57M | 344.92M | 386.25M | 401.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 526.86M | 301.57M | 344.92M | 386.25M | 401.55M |
|
|
|||||